Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million [Yahoo! Finance]
Champions Oncology, Inc. (CSBR)
NASDAQ:AMEX Investor Relations:
championsoncology.com/investors
Company Research
Source: Yahoo! Finance
provider that offers end-to-end oncology solutions, today announced its financial results for its first quarter of fiscal 2025, ended July 31, 2024. First Quarter Highlights: Total revenue increased 12% to $14.1 million Margin improved to 50% Adjusted EBITDA of $2.0 million Net income of $1.3 million Ronnie Morris, CEO of Champions, commented, "As outlined on our year-end earnings call, we're cautiously optimistic that we've weathered the worst of the business downturn and we're poised to emerge leaner and stronger. Our first quarter's performance provided further evidence that we're on a strategic course to more consistently deliver the results we have been striving to achieve." Morris added, "Our comprehensive platform, unique data, and strong team are the key ingredients for future growth that will drive long-term returns for our shareholders." David Miller, CFO of Champions, added, "The first quarter saw a return to profitability as revenue increased 12% to $14.1 mil
Show less
Read more
Impact Snapshot
Event Time:
CSBR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CSBR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CSBR alerts
High impacting Champions Oncology, Inc. news events
Weekly update
A roundup of the hottest topics
CSBR
News
- Champions Oncology (NASDAQ:CSBR) shareholders have endured a 61% loss from investing in the stock three years ago [Yahoo! Finance]Yahoo! Finance
- Champions Oncology Announces Agreement with Weill Cornell Medicine [Yahoo! Finance]Yahoo! Finance
- Champions Oncology Announces Agreement with Weill Cornell MedicineAccesswire
- Champions Oncology (NASDAQ:CSBR) Is In A Strong Position To Grow Its Business [Yahoo! Finance]Yahoo! Finance
- Champions Oncology, Inc. (CSBR) Q1 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
CSBR
Earnings
- 12/12/23 - Beat
CSBR
Sec Filings
- 11/18/24 - Form 4
- 11/18/24 - Form 4
- 11/18/24 - Form 4
- CSBR's page on the SEC website